Longevity InTime BioTech Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Longevity InTime BioTech's estimated annual revenue is currently $8.7M per year.(i)
  • Longevity InTime BioTech's estimated revenue per employee is $155,000

Employee Data

  • Longevity InTime BioTech has 56 Employees.(i)
  • Longevity InTime BioTech grew their employee count by 24% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$78.7M508-2%N/AN/A
#2
$0.9M620%N/AN/A
#3
$1.9M120%N/AN/A
#4
$5.4M3521%N/AN/A
#5
$1.4M929%N/AN/A
#6
$8.7M5624%N/AN/A
#7
$2M130%N/AN/A
#8
$1.4M9-18%N/AN/A
#9
$36M23219%N/AN/A
#10
$15.8M10210%N/AN/A
Add Company

Longevity InTime BioTech develops the real time technology of an online early stages diseases diagnosis by measuring human biodata online. With a hardware, software & a complex of devices we predict & prevent the severe diseases on the not known before earliest stages, which can affect longevity. The company's objective is in predicting & preventing severe diseases by instant distant real time monitoring of 400+ essential health parameters (biomarkers). With participatory of our users we give insights on their health & with AI server, trained on the 70+ years of G20 Big Data, we make personal recommendations how to avoid the upcoming diseases & to extend their own lifespan. We are the global early-stage company with a great team of experienced bioinformaticians, award winning scientists, developers, lawyers & top managers with startup experience, solving the global problem of longevity. Our diverse 30 members team from 11 countries have formed, possibly, the world's biggest biotech startup, in which all team members devoted to humanity's longevity contribute their working capital 24/7 on the option stock basis. Our ultimate goal is to make people live 20+ active & happy years without limitations. We bring personal & national interest solution to each nation & region. On our way to fight TOP 20 severe diseases we have started with fighting obesity & added urgently the coronavirus in our list. Application AntiCoronaVirus is available for download from our website, AntiObesity is #1 in Apple Store in \obesity\ category, BMI Disease Tracker in Google Play. We believe that our customers want to see how their kids will raise their own grandchildren! We plan to deliver this product InTime! Because of COVID-19, almost all the world, first time ever united in fighting early death, we have started this fight in 2018 and welcome everyone to join us on the stock option basis, who is not indifferent to prolonging active & healthy life.

keywords:N/A

N/A

Total Funding

56

Number of Employees

$8.7M

Revenue (est)

24%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Longevity InTime BioTech News

2022-04-13 - Axsome Therapeutics' major depressive disorder drug steps ...

... would not be able to examine facilities in time for a decision date. ... Interestingly, O'Neill isn't filling the biotechs's chief medical officer role,...

2022-04-06 - How the test-to-treat pillar of the US COVID strategy is failing ...

Interestingly, O'Neill isn't filling the biotechs's chief medical officer role, ... potential is part of the "beauty and longevity" of the company's vision.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.3M56-12%N/A
#2
$7.1M5675%$1M
#3
$16.8M57-12%N/A
#4
$7.4M57-25%N/A
#5
$14.9M57-15%N/A